Christian La Fougere
Overview
    Explore the profile of Christian La Fougere including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              229
            
            
              Citations
              4356
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Bitzer M, Gross S, Albert J, Blodt S, Boda-Heggemann J, Borucki K, et al.
  
  
    Z Gastroenterol
    . 2025 Mar;
          63(3):293-336.
    
    PMID: 40064174
  
  
          No abstract available.
      
2.
        
    
    Bitzer M, Gross S, Albert J, Blodt S, Boda-Heggemann J, Borucki K, et al.
  
  
    Z Gastroenterol
    . 2025 Mar;
          63(3):e159-e260.
    
    PMID: 40064172
  
  
          No abstract available.
      
3.
        
    
    Seige L, Zhang B, Heimer J, Spielhofer N, Popescu C, Murray K, et al.
  
  
    Int J Cardiovasc Imaging
    . 2025 Feb;
          41(3):569-577.
    
    PMID: 39953314
  
  
          Cardiopulmonary transit time (CPTT) represents the time needed for the circulation of blood from the right to the left ventricle. This parameter can be measured during dynamic acquisition of rubidium...
      
4.
        
    
    Gross S, Bitzer M, Albert J, Blodt S, Boda-Heggemann J, Borucki K, et al.
  
  
    Z Gastroenterol
    . 2025 Feb;
          63(2):169-203.
    
    PMID: 39919782
  
  
          No abstract available.
      
5.
        
    
    Gross S, Bitzer M, Albert J, Blodt S, Boda-Heggemann J, Borucki K, et al.
  
  
    Z Gastroenterol
    . 2025 Feb;
          63(2):e82-e158.
    
    PMID: 39919781
  
  
          No abstract available.
      
6.
        
    
    Trautwein N, Calderon E, Linder P, Reischl G, Driessen P, Lan W, et al.
  
  
    EJNMMI Phys
    . 2025 Feb;
          12(1):13.
    
    PMID: 39907960
  
  
          Purpose: F-labelled somatostatin receptor tracers have recently gained popularity due to their better spatial resolution, longer half-life and lower costs compared to Ga-labeled tracers. The aim of this study was...
      
7.
        
    
    Calderon E, Kiefer L, Schmidt F, Lan W, Brendlin A, Reinert C, et al.
  
  
    Eur J Nucl Med Mol Imaging
    . 2025 Jan;
    
    PMID: 39883139
  
  
          Purpose: Somatostatin receptor (SSTR)-PET is crucial for effective treatment stratification of neuroendocrine neoplasms (NENs). In highly proliferating or poorly differentiated NENs, dual-tracer approaches using additional [F]FDG PET can effectively identify...
      
8.
        
    
    Wark A, Kim J, Mavriopoulou E, Fougere C, Wiegel T, Scholz C, et al.
  
  
    Strahlenther Onkol
    . 2025 Jan;
    
    PMID: 39808202
  
  
          Purpose: Recent advancements in imaging, particularly 18F-fluorodeoxyglucose positron-emission tomography-computed tomography (FDG-PET/CT), have improved the detection of involved lymph nodes, thus influencing staging accuracy and potentially treatment outcomes. This study is...
      
9.
        
    
    Giannini G, Kafka M, Neuwirt H, Artamonova N, di Santo G, Virgolini I, et al.
  
  
    Clin Genitourin Cancer
    . 2024 Nov;
          23(1):102260.
    
    PMID: 39608079
  
  
          Background: Lu PSMA therapy is increasingly used for metastatic castration-resistant prostate cancer (mCRPC) treatment. However, data on its efficacy and safety in patients previously treated with Ra remain limited. Methods:...
      
10.
        
    
    Trautwein N, Brendlin A, Reischl G, Mattke M, Paulsen F, Loewenheim H, et al.
  
  
    Cancers (Basel)
    . 2024 Nov;
          16(22).
    
    PMID: 39594798
  
  
          SGCs are rare malignancies, accounting for less than 1% of all head and neck cancers [...].